There have been partial vaccine shortages in the US, resulting in fewer people being vaccinated. This situation does much to curtail the effectiveness of the US vaccination programme. While the world is facing shortage of vaccine doses, India in such times intends to manufacture huge amounts of coronavirus vaccine doses, of which 20 million will be exported to nearby neighbours and more to other faraway countries as well.

This shortage in the US is the result of authorities increasing the number of vaccinations in a short amount of time. The supply could not meet with the demand, and the shortage ensued, though it’s still a minor one. As of writing, around 12 million US citizens have been vaccinated, according to the Centers for Disease Control and Prevention.

Sources suggest that a state owned company in India will purchase Coronavirus vaccines from Bharat Biotech and the Serum Institute of India Ltd and will supply to Bangladesh, Afghanistan, Mauritius, Nepal, Sri Lanka and Seychelles. The sources added that some of these supplies might be free and treated as aid.

Also read: Deadlock over farm laws continues: 9th round of talks inconclusive, next meeting on Jan 19

Also read: Coronavirus vaccine LIVE Updates: PM Modi launches nationwide inoculation drive against Covid-19

Addressing the issue of delay in global vaccine rollout, Pfizer Inc and BioNTech on Friday stated that the European Union, Canada and some other countries will also receive fewer does of the Covid-19 vaccine next week because of an upgrade at the Pfizer’s European factory.

Also read: Kashmir issue raised in UK Parliament: Indian mission invites MPs for a dialogue